President Trump announced that the US-Saudi civil nuclear cooperation deal requires Saudi Arabia to normalize relations with Israel via the Abraham Accords, a condition not in the original agreement. The deal focuses on civilian nuclear technology and prohibits military uranium enrichment. This added geopolitical condition complicates regional dynamics, with Israel cautious about potential shifts in US influence. Saudi Arabia must decide if normalization is worth US nuclear cooperation or if it should seek alternatives like China or Russia. The move may also influence US congressional approval, linking the deal to pro-Israel support.
Quest Diagnostics reported a 10.2% revenue increase to $3.04 billion in Q2 2026, driven by a 10% rise in organic revenue and a 13.1% volume increase. Adjusted EPS rose to $3.12, beating analyst expectations of $2.83. Due to strong demand and successf...
HSBC initiated a 'Hold' rating on SpaceX (NASDAQ:SPCX) with the stock at $118.24 amid market volatility following its June IPO. The upcoming lock-up expiry on August 4 will increase the public float from 4.9% to about 12%, potentially pressuring the ...
Scribe Therapeutics, a clinical-stage biotech company focused on CRISPR-based genetic therapies, priced its upsized initial public offering at $15 per share, raising approximately $128.7 million before expenses. The shares will begin trading on Nasda...
Intel reported strong Q1 results with earnings per share of $0.42, doubling analyst estimates of $0.21, and revenue of $16.13 billion, a 25% increase year-over-year. This marks Intel's fastest revenue growth since 2011, fueled by rising demand in dat...
Ripple has made a strategic investment in Notabene to integrate its RLUSD stablecoin into Notabene’s enterprise transaction network, enhancing Ripple’s presence in regulated on-chain transactions. This collaboration aims to combine Notabene’s complia...
